mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.003 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.004 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |